Programma finale completo - SIF - Università degli Studi di Torino

97. Treatment of premenstrual syndrome with continuous low dosage sertralin
Tammaro Emanuela*, Milano W., Milano L., Rundle-Smith S., Petrella C., Capasso A.*
Mental Health Operations Unit District 44 ASL Napoli 1 and *Department of Pharmaceutical
Sciences, University of Salerno, Italy
98. Novel therapeutic opportunities in unipolar depression
Corsi Mauro, W.P.
Psychiatry Centre of Excellence for Drug Discovery, GlaxoSmithkline S.p.A., Verona, Italy
99. Lifestyle interventions on bodyweight gain olanzapine-induced: result from a
randomized-controlled trial
Cammarano Michela*, Milano W., Comazzi M.°, Milano L., Petrella C., Capasso A.*
Unità Operativa Salute Mentale Distretto 44 ASL Napoli1; * Department of Pharmaceutical
Sciences, University of Salerno, Italy; ° Unità di Psichiatria Azienda Ospedaliera di Melegnano
Milano
124
100. Tolerability of antipsychotics in children and adolescents: a prospective study
Alacqua Marianna 1 , Trifirò G. 1,4 , Arcoraci V. 1 , Germanò E. 2 , Gagliano A. 2 , Siracusano M. 2 , Di
Vita G. 3 , Gagliano C. 3 , Spina E. 1, 4
1 Department of Clinical and Experimental Medicine and Pharmacology, Pharmacology Unit,
University of Messina, Italy - 2 Division of Child Neurology and Psychiatry, University of
Messina, Italy - 3 Oasi Institute for Research on Mental Retardation and Brain Aging (IRCCS),
Troina, Italy; 4 IRCCS Centro Neurolesi "Bonino-Pulejo", Messina, Italy
101. Plasma concentrations of quetiapine during coadministration with antiepileptic
drugs in psychiatric patients
D’Arrigo Concetta 1 , Migliardi G. 1 , Santoro V. 2 , Muscatello M.R. 3 , Zoccali R. 3 , Spina E 1,2
1 Section of Pharmacology, Department of Clinical and Experimental Medicine and
Pharmacology, 2 IRCCS Centro Neurolesi “Bonino-Pulejo” and 3 Department of Neurosciences,
Psychiatric and Anesthesiological Sciences, University of Messina, Messina, Italy
102. Potential application of testosterone metabolites in the treatment of
adrenoleukodystrophy
Carissimi Romina 1 , Blasevich M. 1 , Cappa M. 2 , Uziel G. 3, Petroni A. 1
1 Depart. of Pharmacological Sciences, University of Milan, via Balzaretti 9, 20133 Milan, Italy;
2 Depart. of Pediatrics Medicine, Children’s Hospital “Bambino Gesù”, IRCCS, Rome, Italy;
3 Child Neurology Dep., Istituto Neurologico “C. Besta”, Milan, Italy
103. Development of specific biomarkers for als clinical progression: validation and
potential roles in pathogenesis
Bonini Sara A. 1 , Zhao Z. 2 , Lange D. J 3 ., Ho L. 2 , Yemul S. 2 , Wang J. 2 , Salton S. 4 , Memo M. 1 ,
Pasinetti G.M. 2
1 Department of Biomedical Sciences and Biotechnologies, University of Brescia, Brescia, Italy;
2 Department of Psychiatry, 3 Department of Neurology, 4 Department of Neuroscience, Mount
Sinai School of Medicine, New York, New York, USA
pag_sx.indd 1 30/05/2007 5.37.18